BMGL
Basel Medical Group Ltd Ordinary Shares
NASDAQ: BMGL · HEALTHCARE · MEDICAL CARE FACILITIES
$0.58
+3.55% today
Updated 2026-04-30
Market cap
$11.65M
P/E ratio
—
P/S ratio
1.03x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$0 – $7
Volume
0.0M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+4.0
Quality
C2.0
Profitability
F6.7
Valuation
B3/9
Piotroski F-Score
Weak
-1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
$2.59
Margin of safety
+76.81%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 27.30% QoQ
+ 76.81% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -1.69 — distress zone
- Thin margins at -93.70%
- Negative free cash flow $-4.40M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $10.66M | $9.70M | $10.05M | $11.32M | $11.35M |
| Net income | $1.98M | $1.78M | $2.07M | $-12.09M | $-12.09M |
| EPS | — | — | — | — | $-0.45 |
| Free cash flow | $2.70M | $2.59M | $2.50M | $-4.40M | $-4.40M |
| Profit margin | 18.56% | 18.38% | 20.62% | -106.78% | -93.70% |
Peer comparison
Smart narrative
Basel Medical Group Ltd Ordinary Shares trades at $0.58. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -1.69, it sits in the distress. TTM revenue stands at $11.35M. with profit margins at -93.70%. Our DCF model estimates intrinsic value at $2.59.
Frequently asked questions
What is Basel Medical Group Ltd Ordinary Shares's stock price?
Basel Medical Group Ltd Ordinary Shares (BMGL) trades at $0.58.
Is Basel Medical Group Ltd Ordinary Shares overvalued?
Smart Value Score 31/100 (Grade F, Strong Sell). DCF value $2.59.
What is the price target of Basel Medical Group Ltd Ordinary Shares (BMGL)?
The analyst target price is $—, representing NaN% downside from the current price of $0.58.
What is the intrinsic value of Basel Medical Group Ltd Ordinary Shares (BMGL)?
Based on our DCF model, intrinsic value is $2.59, a +76.8% margin of safety versus $0.58.
What is Basel Medical Group Ltd Ordinary Shares's revenue?
TTM revenue is $11.35M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-1.69 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.03x
ROE-163.60%
Beta—
50D MA$0.61
200D MA$1.25
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—